Jones Trading Upgrades Deciphera (DCPH) to Buy, sees higher probability of success for vimseltinib
Tweet Send to a Friend
(Updated - October 30, 2023 5:54 PM EDT)
Jones Trading analyst Soumit Roy upgraded Deciphera (NASDAQ: DCPH) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jones Trading analyst Soumit Roy upgraded Deciphera (NASDAQ: DCPH) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
